ALBUTEROL SULFATE INHALATION AEROSOL W/H

Albuterol Sulfate Inhalation Aerosol with HFA is a prescription-only medication delivered via metered-dose inhaler, with each actuation providing 108 micrograms of albuterol sulfate, equivalent to 90 micrograms of albuterol base, from a 8.5-gram canister containing 200 inhalations. The product must be stored at room temperature between 59°F and 77°F, protected from extreme heat or cold, and must not be punctured, exposed to flame, or thrown into fire due to risk of rupture above 120°F. It is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months. Labeling requirements include the National Stock Number, manufacturer name, date of manufacture, expiration date, contract number, and lot number. The item is regulated by the FDA and must comply with the latest Hazard Communication Standard, requiring submission of Safety Data Sheets and HCS-compliant labels prior to contract award. Packaging must conform to Medical Marking Standard No. 1 in lieu of MIL-STD-129, with each unit securely sealed and shipped in commercial containers suitable for safe delivery via common carrier. The contract specifies delivery of 8 units FOB destination within 20 days, with zero quantity variance permitted, and inspection and acceptance occurring at the delivery point. The supplier is required to comply with all DLA packaging, labeling, and technical standards, and must provide documentation for verification through the DLA Master List of Technical and Quality Requirements referenced in the solicitation. The contract solicitation number is SPE2DP-26-T-4207, with responses due by July 27, 2026, and the authorized supplier identifiers include TEVA PHARMACEUTICALS USA, INC. and PERRIGO DIRECT INC.